MARÍA ÁNGEL
GARCÍA CHAVES
PROFESORA TITULAR DE UNIVERSIDAD
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (26)
2023
-
Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma
Cancers, Vol. 15, Núm. 14
2021
-
Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma
Molecular Oncology, Vol. 15, Núm. 2, pp. 407-428
2020
2018
-
Activating transcription factor 4 modulates TGFb-induced aggressiveness in triple-negative breast cancer via SMad2/3/4 and mTORC2 signaling
Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5697-5709
-
Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile
Cancer Letters, Vol. 429, pp. 78-88
2017
-
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: A pilot study focused on pancreatic and ovarian cancer
Scientific Reports, Vol. 7, Núm. 1
-
Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism
Expert Reviews in Molecular Medicine, Vol. 19
-
Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity
Scientific Reports, Vol. 7
2016
-
Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells
Scientific Reports, Vol. 6
-
Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what’s new?
Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 8, pp. 877-890
2014
-
Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction
Cytotherapy, Vol. 16, Núm. 9, pp. 1229-1237
-
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497
-
HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound
Oncotarget, Vol. 5, Núm. 11, pp. 3590-3606
-
The impact of PKR activation: From neurodegeneration to cancer
FASEB Journal, Vol. 28, Núm. 5, pp. 1965-1974
2013
-
Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence
Drug Design, Development and Therapy, Vol. 7, pp. 1301-1313
-
Enantiospecific synthesis of heterocycles linked to purines: Different apoptosis modulation of enantiomers in breast cancer cells
Current Medicinal Chemistry, Vol. 20, Núm. 38, pp. 4924-4934
-
How can nanotechnology help to repair the body? Advances in cardiac, skin, bone, cartilage and nerve tissue regeneration
Materials, Vol. 6, Núm. 4, pp. 1333-1359
-
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation
Cellular Oncology, Vol. 36, Núm. 4, pp. 289-301
2012
-
Functionalized nanostructures with application in regenerative medicine
International Journal of Molecular Sciences, Vol. 13, Núm. 3, pp. 3847-3886